Trend Results : New England Journal of Medicine

Blog Post Results (1-20 of 703)


Telomerase targeting drug demonstrates benefit in myelofibrosis treatment

ROCHESTER, Minn. — Imetelstat, a novel drug that targets telomerase, has demonstrated potential value in treating patients with myelofibrosis, according to the results of a study published today in the New England Journal of Medicine. Journalists: Sounds bites with Dr. Tefferi are available in the download. "We observed that Imetelstat was active and induced morphologic […]

Anti-GMO in the NEJM

A recent commentary published in the New England Journal of Medicine (NEJM) by Philip J. Landrigan and Charles Benbrook has sparked some controversy. Landrigan and Benbrook are publishing in a medical journal because they claim the issue of genetically modified organisms (GMOs) is a public health issue. They use extremely strained logic and misrepresentation to [...]

Aaron Belkin, Ph.D: Transgender medical costs are negligible for DoD

There’s a piece in the New England Journal of Medicine written by Aaron Belkin, Ph.D. entitled Caring for Our Transgender Troops — The Negligible Cost of Transition-Related Care to convince Defense Secretary Ashton Carter to lift the ban on transgender military personnel. Doctor Belkin, Ph.D says that the military can easily afford to allow transgender […]

Health Care Innovation Isn't About Smart Phone Apps, Penn Medicine Researchers Say

Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Show More Summary

The New England Journal Of Medicine Fact-Checks The Republican Debate

The New England Journal of Medicine, the most important medical periodical in the world, has a few bones to pick with the Republican Party’s would-be presidential candidates. In an editorial, the journals’ editors attack the stance held by most of the Republican hopefuls that Planned Parenthood should be defunded. A separate opinion piece argues that there is nothing wrong […]

New Approach to Decades Old Treatment Yields Increased Survival for Some Prostate Cancer Patients

Research coordinated by the ECOG-ACRIN Cancer Research Group and just published in the The New England Journal of Medicine, examines the outcomes of giving the chemotherapy drug docetaxel at the start of androgen deprivation therapy for patients with metastatic hormone-sensitive prostate cancer. Show More Summary

UNC Doctors Analyze Treatment Options for Gallbladder Disease

A new review article, published in the July 23, 2015 issue of The New England Journal of Medicine, analyzes the pros and cons of five different interventional approaches to gallbladder disease.

Study Highlights Pneumonia Hospitalizations Among US Adults

Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention (CDC) and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center.

Is “Amazing Grace” Mediated Through The Placebo Effect?

Source: Chronicle Mike Magee This week, Ted Kaptchuk and Franklin Miller published a seminal article in the New England Journal of Medicine titled, “Placebo Effects in Medicine”. I believe it will be remembered for many years,...Show More Summary

Diabetes drug’s happy side effect: Weight loss

2 months agoHealth : The Checkup

A study in the New England Journal of Medicine reports that taking daily shots of liraglutide (marketed as Saxenda) can help overweight or obese patients lose weight -- a lot of it. Patients taking the medication lost an average of more than 12 pounds, twice as much as those on a placebo, after 56 weeks.Read full article >>

The Importance of Placebo Effects to Medical Care

The "placebo effect" is often described as events that occur when patients show improvement from treatments that contain no active ingredients. A "Perspectives" article in the July 2 issue of The New England Journal of Medicine proposes that placebo effects be more broadly defined to reflect their role as a valuable component of medical care.

How Institutional Conflicts of Interest Exacerbate the Anechoic Effect - the Example of ASCO Fearing "Biting the Hand that Feeds You"

As we recently discussed (here, here, here and here), in May, 2015, the New England Journal of Medicine, arguably the world's foremost medical journal, published an editorial and a three-part commentary arguing that current concerns about the effects of financial conflicts of interest (COI) on health care are overblown(1-4). Show More Summary

Promising New Drug Combo Offers Hope for People Battling Melanoma

Monte Shaheen, MD, and colleagues from around the country recently published a paper in the New England Journal of Medicine about a promising new treatment for melanoma.

Perspective on TPP in an unlikely place—a medical journal

A new take on TPP, which appears in the New England Journal of Medicine, gives me another reason to give the TPP a thumbs down.

Study On Preventing College Rape Shows Us How We Should Run The World

There's a great study published today in the New England Journal of Medicine on a program for teaching college women how to behave in order to lower their risk of being sexually assaulted. The women who were assigned to take the four-part, small group training sessions were half as likely to [...]

Has criticism of the pharmaceutical industry gone too far?

The New England Journal of Medicine (NEJM) called the question: Has criticism of the pharmaceutical industry, and of physician relationships with that industry, gone too far?  Are self-righteous “pharmascolds” blocking the kind of essential collaboration that brought streptomycin and other lifesaving treatments to market?  The editorial by Dr. Show More Summary

Are Financial Conflicts of Interest in Medical Research Overblown?

The New England Journal of Medicine, the world's most influential medical journal, recently published three highly RELATED POST PROFILESHARE

Another One Bites The Dust: On The Death Of A Social Media Site For Doctors

Like a certain late lamented parrot, CardioExchange is no more. It has ceased to be. The website was started by the New England Journal of Medicine and the Massachusetts Medical Society more than 5 years ago in the wake of the explosive and ubiquitous growth of social media. But the rise of social media also provoked tremendous uncertainty and [...]

Are commercial conflicts of interests justifiable in medical journals?

A group of former senior editors criticize a 'seriously flawed and inflammatory attack' by The New England Journal of Medicine on what that journal believes have become overly stringent policies on conflicts of interest.

How to Prevent Mental Health Problems? Begin at the Beginning With Infants and Toddlers

A new report recently published in the New England Journal of Medicine shows a downward trajectory in severe mental health issues for children between the ages of 6 and 17. On the surface, this is good news. Yet on the flip side, the...Show More Summary

Copyright © 2015 Regator, LLC